Overall survival
HGG, deaths, MM
The median (95% CI) overall survival (OS) was 14.5 (6.8, 23.2), 13.5 (10.4, 17.6), 17.6 (9.5, 32.2) and 33.9 (2.9, 44.6) months in the ATC, BTC, HGG and MM cohorts, respectively. In the ASI cohort, the median OS was 21.8 (3.4, NR) months. All three patients in the ASI cohort died during the study. OS could not be estimated owing to the low numbers of deaths in the LGG (